Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen

Nature Communications

Volumn 4, Issue , 2013, Pages

  Kurup, Samarchith P ^a   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; GENE EXPRESSION; HOST-PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNITY; MOLECULAR ANALYSIS; PATHOGEN; PERSISTENCE; PROTOZOAN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNOREGULATION; INNATE IMMUNITY; MEDICAL PARAMETERS; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATHOGEN CLEARANCE; TRANSGENICS; TRYPANOSOMA CRUZI;

BACTERIA (MICROORGANISMS); PROTOZOA; TRYPANOSOMA CRUZI;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; FEMALE; FLAGELLIN; GENE EXPRESSION; MICE; MICE, INBRED C57BL; PORINS; SIGNAL TRANSDUCTION; TRANSFECTION; TRYPANOSOMA CRUZI;

EID: 84889600741     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3616     Document Type: Article

References (51)

1. Medzhitov, R., Preston-Hurlburt, P. & Janeway, Jr. C. A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997). (Pubitemid 27334820)
2. Fearon, D. T. & Locksley, R. M. The instructive role of innate immunity in the acquired immune response. Science 272, 50-53 (1996).
3. Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947-950 (2001). (Pubitemid 32976167)
4. Janeway, Jr. C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002). (Pubitemid 34293424)
5. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680 (2001). (Pubitemid 32747155)
6. Costales, J. A., Daily, J. P. & Burleigh, B. A. Cytokine-dependent andindependent gene expression changes and cell cycle block revealed in Trypanosoma cruzi-infected host cells by comparative mRNA profiling. BMC Genomics 10, 252 (2009).
7. Padilla, A. M., Simpson, L. J. & Tarleton, R. L. Insufficient TLR activation contributes to the slow development of CD8 T cell responses in Trypanosoma cruzi infection. J. Immunol. 183, 1245-1252 (2009).
8. Campos, M. A. et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167, 416-423 (2001). (Pubitemid 32567807)
9. Bafica, A. et al. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177, 3515-3519 (2006). (Pubitemid 44359881)
10. Oliveira, A. C. et al. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8 T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. PLoS Pathog. 6, e1000870 (2010).
11. Tarleton, R. L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19, 430-434 (2007). (Pubitemid 47284855)
12. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001). (Pubitemid 32391041)
13. Miao, E. A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7, 569-575 (2006). (Pubitemid 43797337)
14. Singleton, T. E., Massari, P. &Wetzler, L. M. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol. 174, 3545-3550 (2005). (Pubitemid 40354063)
15. Lorenzi, H. A., Vazquez, M. P. & Levin, M. J. Integration of expression vectors into the ribosomal locus of Trypanosoma cruzi. Gene 310, 91-99 (2003). (Pubitemid 36703303)
16. Garg, N., Nunes, M. P. & Tarleton, R. L. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 158, 3293-3302 (1997). (Pubitemid 127484046)
17. Takeda, K. & Akira, S. TLR signaling pathways. Semin. Immunol. 16, 3-9 (2004). (Pubitemid 38147427)
18. Reinhardt, R. L., Hong, S., Kang, S. J., Wang, Z. E. & Locksley, R. M. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177, 1618-1627 (2006). (Pubitemid 44092497)
19. Berg, R. E., Cordes, C. J. & Forman, J. Contribution of CD8 T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 32, 2807-2816 (2002). (Pubitemid 35238173)
20. Cui, W., Joshi, N. S., Jiang, A. & Kaech, S. M. Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine 27, 2177-2187 (2009).
21. Stetson, D. B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003). (Pubitemid 37248622)
22. Bustamante, J. M., Bixby, L. M. & Tarleton, R. L. Drug-induced cure drives conversion to a stable and protective CD8 T central memory response in chronic Chagas disease. Nat. Med. 14, 542-550 (2008). (Pubitemid 351655210)
23. Padilla, A. M., Bustamante, J. M. & Tarleton, R. L. CD8 T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 21, 385-390 (2009).
24. Tarleton, R. L. Depletion of CD8 T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144, 717-724 (1990). (Pubitemid 20036107)
25. Martin, D. L. et al. CD8 T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2, e77 (2006).
26. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998). (Pubitemid 28361303)
27. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F. & Lanzavecchia, A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1- polarizing program in dendritic cells. Nat. Immunol. 6, 769-776 (2005). (Pubitemid 43090462)
28. Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424 (2006). (Pubitemid 43290850)
29. Coffman, R. L., Sher, A. & Seder, R. A. Vaccine adjuvants: putting innate immunity to work. Immunity 33, 492-503 (2010).
30. Gurunathan, S., Prussin, C., Sacks, D. L. & Seder, R. A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4, 1409-1415 (1998). (Pubitemid 28553464)
31. Salazar-Gonzalez, R. M. et al. Salmonella flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo. J. Immunol. 179, 6169-6175 (2007).
32. Ibegbu, C. C. et al. Expression of killer cell lectin-like receptor G1 on antigenspecific human CD8 T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 174, 6088-6094 (2005). (Pubitemid 40663797)
33. Iwasaki, A. & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
34. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995 (2004). (Pubitemid 41057715)
35. Coats, S. R., Do, C. T., Karimi-Naser, L. M., Braham, P. H. & Darveau, R. P. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell Microbiol. 9, 1191-1202 (2007). (Pubitemid 46547138)
36. Reife, R. A. et al. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: Differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol. 8, 857-868 (2006).
37. Montminy, S. W. et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7, 1066-1073 (2006). (Pubitemid 44420651)
38. Wolfgang, M. C., Jyot, J., Goodman, A. L., Ramphal, R. & Lory, S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl Acad. Sci. USA 101, 6664-6668 (2004). (Pubitemid 38586031)
39. Amigorena, S. & Savina, A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr. Opin. Immunol. 22, 109-117 (2010).
40. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146 (2003). (Pubitemid 37328691)
41. Mescher, M. F. et al. Signals required for programming effector and memory development by CD8 T cells. Immunol. Rev. 211, 81-92 (2006). (Pubitemid 43882963)
42. Bocek, Jr. P., Foucras, G. & Paul, W. E. Interferon gamma enhances both in vitro and in vivo priming of CD4 T cells for IL-4 production. J. Exp. Med. 199, 1619-1630 (2004). (Pubitemid 38821995)
43. Kang, S. M. et al. MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J. Virol. 85 (2011).
44. Poyet, J. L. et al. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276, 28309-28313 (2001).
45. Koenen, T. B. et al. The inflammasome and caspase-1 activation: A new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology 152, 3769-3778 (2011).
46. Ahrens, S. et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 36, 635-645 (2012).
47. Martin, D. L. & Tarleton, R. L. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J. Immunol. 174, 1594-1601 (2005).
48. Phythian-Adams, A. T. et al. CD11c depletion severely disrupts Th2 induction and development in vivo. J. Exp. Med. 207, 2089-2096 (2010).
49. Turley, S. J., Fletcher, A. L. & Elpek, K. G. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat. Rev. Immunol. 10, 813-825 (2010).
50. Mayer, K. D. et al. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production. J. Immunol. 174, 7732-7739 (2005). (Pubitemid 40806279)
51. Cummings, K. L. & Tarleton, R. L. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129, 53-59 (2003). (Pubitemid 36703222)